About this event
This year’s conference promises to unlock the potential of innovative technologies, improve efficiencies, and reduce costs in biologics production. With over 3200 global attendees and more than 250 hours of scientific content, the event is an excellent opportunity for networking, learning, and exploring the latest advancements in the field.
Michelle Stretz, Associate Director of Business Development, and Matt F, Business Development Manager will represent VGXI at the Gene Therapy Manufacturing Track. Their expertise in the development and manufacturing of nucleic acid-based products positions them as a key player in the biotech community, continually pushing the boundaries of what is possible in gene therapy applications.
Where: Hynes Convention Center, Boston, Massachusetts
